- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293251
Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
September 24, 2017 updated by: Maha omar mahmoud said, Assiut University
- determine whether cataract surgery has a major effect on outcomes of trabeculectomy with MMC or not.
- Success rates of trabeculectomy with MMC in Queen Elizabeth hospital.
- recurrence rate of uveitis after glaucoma surgery
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
- determine different success rates of trabeculectomy with MMC undergone in QE hospital, UK.
- determine different complications and effect of cataract surgery on the outcome of glaucoma surgery
Study Type
Observational
Enrollment (Anticipated)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Assiut
-
Egypt, Assiut, Egypt
- Maha Said
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
cohort of patient documented on the database system of Queen Elizabeth hospital
Description
Inclusion Criteria:
- Fesh trabeculectomy surgeries
Exclusion Criteria:
- recurrent surgeries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
uveitic/ POAG
Outcomes, success rates, complications of trabeculectomy with MMC in Uveitic glaucoma
|
glaucoma surgeries
Other Names:
|
POAG
Outcomes, success rates, complications of trabeculectomy with MMC and I stent in this groups
|
glaucoma surgeries
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rates
Time Frame: 5 year period
|
IOP less 21 mmHg
|
5 year period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Dr Kamel Soliman, professor, Assiut University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Anticipated)
October 29, 2018
Study Completion (Anticipated)
December 29, 2018
Study Registration Dates
First Submitted
September 20, 2017
First Submitted That Met QC Criteria
September 24, 2017
First Posted (Actual)
September 26, 2017
Study Record Updates
Last Update Posted (Actual)
September 26, 2017
Last Update Submitted That Met QC Criteria
September 24, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1111
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
undecided yet
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Outcomes of Trabeculectomy With MMC
-
Ain Shams UniversityUnknownPhysician Satisfaction With the Outcomes of Cytotoxic DrugsEgypt
-
Baylor College of MedicineThe University of Texas Health Science Center, Houston; Universitaire Ziekenhuizen... and other collaboratorsActive, not recruiting
-
University of MemphisUniversity of Tennessee Health Science Center; USP Labs, Inc.Completed
-
Sohag UniversityNot yet recruitingVoice and Swallow Outcomes After Injection Laryngoplasty in Patients With Glottal Insufficiency
-
Government College University FaisalabadActive, not recruitingExperiences of Psychitherapeutic Outcomes in Women Victims of Domestic ViolencePakistan
-
Changsha Hospital for Maternal and Child Health...CompletedOxytocin | Labor Induction | Mode of Delivery | Pregnancy OutcomesChina
-
Portsmouth Hospitals NHS TrustRecruitingAdult Hospital Patients at Risk of Adverse OutcomesUnited Kingdom
-
Mel Shiuann-Sheng LeeNovartisCompletedFunctional Outcomes | Prevention of BMD Loss After THR | Serum Markers of Bone TurnoverTaiwan
-
University of PennsylvaniaMerakey Behavioral HealthCompletedImpact of Feedback on Symptoms and Trust/Respect on OutcomesUnited States
-
Institut für Pharmakologie und Präventive MedizinWithdrawnEffectivity of RIPC in Outcomes of TAVI ProcedureGermany
Clinical Trials on Trabeculectomy with MMC
-
Mansoura UniversityNot yet recruitingPrimary Congenital Glaucoma
-
Pro Top & Mediking Company LimitedUnknown
-
Vanak Eye Surgery CenterCompletedRefractory Primary Open Angle GlaucomaIran, Islamic Republic of
-
Shanghai Eye Disease Prevention and Treatment CenterUnknown
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
L.V. Prasad Eye InstituteCompletedPrimary Congenital Glaucoma | Developmental Glaucoma | Infantile GlaucomaIndia
-
UroGen Pharma Ltd.CompletedCarcinoma of Urinary Bladder, SuperficialIsrael, Spain, Italy, Switzerland
-
Queen's UniversityGlaucoma Research & Education GroupWithdrawn
-
Athens Vision Eye InstituteCompleted